基于知识规划的Halcyon共面VMAT治疗脑转移瘤的可行性。

IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
In vivo Pub Date : 2025-03-01 DOI:10.21873/invivo.13893
Yusuke Sakai, Kazuki Kubo, Kenji Matsumoto, Makoto Hosono, Hajime Monzen
{"title":"基于知识规划的Halcyon共面VMAT治疗脑转移瘤的可行性。","authors":"Yusuke Sakai, Kazuki Kubo, Kenji Matsumoto, Makoto Hosono, Hajime Monzen","doi":"10.21873/invivo.13893","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>This study aimed to clarify the feasibility of creating coplanar single-isocenter volumetric modulated arc therapy (SI-VMAT) with a Halcyon using a knowledge-based planning system based on non-coplanar plans for treating multiple brain metastases.</p><p><strong>Patients and methods: </strong>A knowledge-based RapidPlan (RP) planning model was built using 32 TrueBeam SI-VMAT plans including one full arc and three non-coplanar partial arcs. To confirm its applicability across different beam geometries using the Halcyon system, the model was validated on the basis of the root-mean-square error (RSME), deviation rate, and absolute differences between estimated and actual dose-volume histograms (DVHs). Dosimetric performance of TrueBeam and Halcyon plans was then compared for 10 patients.</p><p><strong>Results: </strong>The average RSME values for the Halcyon and TrueBeam plans were 0.75±0.40 Gy and 0.46±0.28 Gy, respectively (<i>p</i><0.05). Using the model for Halcyon plan creation, deviations from the estimated DVH boundaries were mainly observed in the low-dose region (<9 Gy), while the actual DVH closely aligned with the estimated DVH in the intermediate- and higher-dose regions. For comparison of dosimetric performance, statistically significant differences were found in the gradient index, conformity index, and normal brain volumes receiving ≥12 Gy, ≥18 Gy, and ≥27 Gy. However, these differences were deemed clinically negligible, with less than 1% disparity in the above doses to the normal brain.</p><p><strong>Conclusion: </strong>The RP model can effectively predict doses for Halcyon, regardless of different beam configurations. Coplanar SI-VMAT with Halcyon can feasibly be used in clinical applications, such as the treatment of multiple brain metastases.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"39 2","pages":"894-901"},"PeriodicalIF":1.8000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11884445/pdf/","citationCount":"0","resultStr":"{\"title\":\"Feasibility of Coplanar VMAT for Brain Metastases Using Halcyon With Knowledge-based Planning from Non-coplanar Plan.\",\"authors\":\"Yusuke Sakai, Kazuki Kubo, Kenji Matsumoto, Makoto Hosono, Hajime Monzen\",\"doi\":\"10.21873/invivo.13893\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background/aim: </strong>This study aimed to clarify the feasibility of creating coplanar single-isocenter volumetric modulated arc therapy (SI-VMAT) with a Halcyon using a knowledge-based planning system based on non-coplanar plans for treating multiple brain metastases.</p><p><strong>Patients and methods: </strong>A knowledge-based RapidPlan (RP) planning model was built using 32 TrueBeam SI-VMAT plans including one full arc and three non-coplanar partial arcs. To confirm its applicability across different beam geometries using the Halcyon system, the model was validated on the basis of the root-mean-square error (RSME), deviation rate, and absolute differences between estimated and actual dose-volume histograms (DVHs). Dosimetric performance of TrueBeam and Halcyon plans was then compared for 10 patients.</p><p><strong>Results: </strong>The average RSME values for the Halcyon and TrueBeam plans were 0.75±0.40 Gy and 0.46±0.28 Gy, respectively (<i>p</i><0.05). Using the model for Halcyon plan creation, deviations from the estimated DVH boundaries were mainly observed in the low-dose region (<9 Gy), while the actual DVH closely aligned with the estimated DVH in the intermediate- and higher-dose regions. For comparison of dosimetric performance, statistically significant differences were found in the gradient index, conformity index, and normal brain volumes receiving ≥12 Gy, ≥18 Gy, and ≥27 Gy. However, these differences were deemed clinically negligible, with less than 1% disparity in the above doses to the normal brain.</p><p><strong>Conclusion: </strong>The RP model can effectively predict doses for Halcyon, regardless of different beam configurations. Coplanar SI-VMAT with Halcyon can feasibly be used in clinical applications, such as the treatment of multiple brain metastases.</p>\",\"PeriodicalId\":13364,\"journal\":{\"name\":\"In vivo\",\"volume\":\"39 2\",\"pages\":\"894-901\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11884445/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"In vivo\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21873/invivo.13893\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"In vivo","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21873/invivo.13893","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

背景/目的:本研究旨在阐明利用基于非共面计划的知识计划系统,利用Halcyon创建共面单等中心体积调制电弧疗法(SI-VMAT)治疗多发性脑转移瘤的可行性。患者和方法:基于知识的RapidPlan (RP)计划模型使用32个TrueBeam SI-VMAT计划,包括一个全弧和三个非共面部分弧。为了验证其在Halcyon系统中不同光束几何形状下的适用性,根据均方根误差(RSME)、偏差率以及估计剂量-体积直方图(DVHs)与实际剂量-体积直方图之间的绝对差值对模型进行了验证。然后比较了10例患者的TrueBeam和Halcyon计划的剂量学性能。结果:Halcyon和TrueBeam方案的平均RSME值分别为0.75±0.40 Gy和0.46±0.28 Gy (p)结论:RP模型可以有效预测Halcyon在不同光束配置下的剂量。与Halcyon共面SI-VMAT在治疗多发性脑转移等临床应用中是可行的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Feasibility of Coplanar VMAT for Brain Metastases Using Halcyon With Knowledge-based Planning from Non-coplanar Plan.

Background/aim: This study aimed to clarify the feasibility of creating coplanar single-isocenter volumetric modulated arc therapy (SI-VMAT) with a Halcyon using a knowledge-based planning system based on non-coplanar plans for treating multiple brain metastases.

Patients and methods: A knowledge-based RapidPlan (RP) planning model was built using 32 TrueBeam SI-VMAT plans including one full arc and three non-coplanar partial arcs. To confirm its applicability across different beam geometries using the Halcyon system, the model was validated on the basis of the root-mean-square error (RSME), deviation rate, and absolute differences between estimated and actual dose-volume histograms (DVHs). Dosimetric performance of TrueBeam and Halcyon plans was then compared for 10 patients.

Results: The average RSME values for the Halcyon and TrueBeam plans were 0.75±0.40 Gy and 0.46±0.28 Gy, respectively (p<0.05). Using the model for Halcyon plan creation, deviations from the estimated DVH boundaries were mainly observed in the low-dose region (<9 Gy), while the actual DVH closely aligned with the estimated DVH in the intermediate- and higher-dose regions. For comparison of dosimetric performance, statistically significant differences were found in the gradient index, conformity index, and normal brain volumes receiving ≥12 Gy, ≥18 Gy, and ≥27 Gy. However, these differences were deemed clinically negligible, with less than 1% disparity in the above doses to the normal brain.

Conclusion: The RP model can effectively predict doses for Halcyon, regardless of different beam configurations. Coplanar SI-VMAT with Halcyon can feasibly be used in clinical applications, such as the treatment of multiple brain metastases.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
In vivo
In vivo 医学-医学:研究与实验
CiteScore
4.20
自引率
4.30%
发文量
330
审稿时长
3-8 weeks
期刊介绍: IN VIVO is an international peer-reviewed journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of physiology, pathology and disease management. The topics of IN VIVO include: 1. Experimental development and application of new diagnostic and therapeutic procedures; 2. Pharmacological and toxicological evaluation of new drugs, drug combinations and drug delivery systems; 3. Clinical trials; 4. Development and characterization of models of biomedical research; 5. Cancer diagnosis and treatment; 6. Immunotherapy and vaccines; 7. Radiotherapy, Imaging; 8. Tissue engineering, Regenerative medicine; 9. Carcinogenesis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信